ABOUT

Meet our Board of Directors

Experienced leaders providing strategic direction and oversight for Thryv Therapeutics as it develops next-generation precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.

Directors

Paul F. Truex, MBA

CHAIRMAN OF THE BOARD & CHIEF EXECUTIVE OFFICER

Read biography →

Robert Booth, PhD

DIRECTOR

Read biography →

Daniel Hétu, MD, MBA

DIRECTOR

Read biography →

Melissa Koomey, MBA

DIRECTOR

Read biography →

Jean-François Pariseau, MSc, MBA, ICD.D

DIRECTOR

Read biography →

Amy Rudolph, PhD

DIRECTOR

Read biography →

Marc-Olivier Sirard, CPA

DIRECTOR

Read biography →

Observers

Youssef Bennani, PhD, MBA

OBSERVER

Read biography →

Maxime Daigle, CPA

OBSERVER

Read biography →

Sarah Williams, PhD

OBSERVER

Read biography →

Scott Weiner, MBA

OBSERVER

Read biography →